View Financial HealthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsCarebook Technologies 배당 및 자사주 매입배당 기준 점검 0/6Carebook Technologies 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률0%자사주 매입 수익률총 주주 수익률0%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Feb 25+ 1 more updateCarebook Technologies' Common Shares to be Delisted from the TSX Venture Exchange at the Close of Trading on or about February 25, 2025Carebook Technologies Inc. (‘Carebook’ or the ‘Company’) announced the closing of the previously announced plan of arrangement (the ‘Transaction’) pursuant to which UIL Limited (‘UIL’) has acquired all of the common shares of Carebook (the ‘Common Shares’) not already owned by UIL and its affiliates or associates, at a price of $0.10 per Common Share (the ‘Consideration’), for aggregate consideration to the shareholders of Carebook (other than UIL and its associates or associates) of $4,170,618.90. The Transaction received overwhelming support from the Company's shareholders at a special meeting held on February 18, 2025, and the Transaction received final court approval on February 20, 2025. As a result of the Transaction, the Common Shares are expected to be delisted from the TSX Venture Exchange (‘TSXV’) at the close of trading on or about February 25, 2025. The Company also intends to submit an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the Company's public reporting requirements.공시 • Jan 03UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million.UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million on January 2, 2025. UIL will acquire all of the common shares (the "Common Shares") in the capital of Carebook, other than those Common Shares already owned by UIL or its affiliates and associates, by way of a plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, holders of Common Shares, other than those Common Shares already owned by UIL or its affiliates and associates, will receive CAD 0.10 per Common Share (the "Consideration"). The Consideration represents a premium of approximately 122%, to the closing price of the Common Shares of CAD 0.045 on the TSX Venture Exchange (the "TSXV") on January 2, 2025, the last trading day prior to the announcement of the Arrangement. Completion of the Arrangement is subject to court approval and various closing conditions, including the approval of at least (i) two-thirds (66 2/3%) of the votes cast by shareholders present in person or represented by proxy at the special meeting of the shareholders to be called to approve the Arrangement (the "Special Meeting") (each holder of Common Shares being entitled to one vote per Common Share) and (ii) the approval of a simple majority of the holders of Common Shares present in person or represented by proxy at the Special Meeting, excluding the votes of UIL and its affiliates and associates and any other shareholders required to be excluded for purposes of the "minority approval" requirement under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101") in the context of a "business combination" (the "Minority Shareholders"). Further details regarding applicable voting requirements will be contained in a management information circular to be filed on SEDAR+ at www.sedarplus.com and mailed to Carebook's shareholders in connection with the Special Meeting to approve the Arrangement. The signing of the Arrangement Agreement and the approval of the Arrangement followed the unanimous approval of the board of directors of the Company (the "Board") (with Alasdair Younie abstaining) following the unanimous recommendation of a committee of independent directors (the "Special Committee") of the Board. The Arrangement is expected to close in the first quarter of 2025, subject to the satisfaction of customary closing conditions. The Arrangement will be completed pursuant to a court-approved plan of arrangement under section 192 of the Canada Business Corporations Act and is subject to satisfaction of customary closing conditions for transactions of this nature, including court approval and the approval of the shareholders of Carebook, as further set out below. Immediately following the completion of the Arrangement, the Common Shares will be delisted from the TSXV and it is anticipated that the Company will make an application to cease to be a reporting issuer, following the approval of which, the Company will no longer be subject to the reporting requirements of applicable Canadian securities legislation. BDO Canada LLP is acting as financial advisor and fairness opinion provider to the Special Committee, and Stikeman Elliott LLP is acting as legal advisor to the Special Committee and the Company. Norton Rose Fulbright Canada LLP is acting as legal advisor to UIL on the proposed transaction.공시 • Nov 08Carebook Technologies Inc. to Report Q3, 2024 Results on Nov 15, 2024Carebook Technologies Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024공시 • Aug 22Carebook Technologies Inc. Provides Earnings Guidance for the Fiscal Year 2024Carebook Technologies Inc. provided earnings guidance for the fiscal year 2024. For the period, the company continues to be positive for 2024 poised to achieve significant revenue growth.공시 • Aug 15Carebook Technologies Inc. to Report Q2, 2024 Results on Aug 21, 2024Carebook Technologies Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 21, 2024공시 • May 11Carebook Technologies Inc. to Report Q1, 2024 Results on May 15, 2024Carebook Technologies Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 15, 2024공시 • Apr 03Carebook Technologies Inc. Provides Earnings Guidance for the Full Year 2024Carebook Technologies Inc. provided earnings guidance for the full year 2024. The company's financial outlook continues to be positive for 2024. The company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. The company's strong organic growth and efficient cost management initiatives will allow the company to continue to successfully execute on its strategy.공시 • Apr 02Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024.공시 • Mar 19Carebook Technologies Inc. to Report Fiscal Year 2023 Results on Apr 01, 2024Carebook Technologies Inc. announced that they will report fiscal year 2023 results at 9:30 AM, US Eastern Standard Time on Apr 01, 2024공시 • Dec 12Carebook Technologies Inc. announced that it has received CAD 2 million in funding from ICM LimitedOn December 11, 2023, Carebook Technologies Inc. closed the transaction.공시 • Oct 24Carebook Technologies Inc. to Report Q3, 2023 Results on Nov 10, 2023Carebook Technologies Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 10, 2023공시 • Aug 23Carebook Technologies Inc. Provides Earnings Guidance for the Year 2023Carebook Technologies Inc. provided earnings guidance for the year 2023. For the period, the company expects financial outlook continues to be positive for 2023. The Company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. Carebook's strong organic growth and efficient cost management initiatives will allow the Company to continue to successfully execute on its strategy. Carebook is expecting to maintain strong performance in 2023 for the entire Company as a whole.공시 • Aug 09Carebook Technologies Inc. to Report Q2, 2023 Results on Aug 22, 2023Carebook Technologies Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 22, 2023공시 • Jun 29Carebook Technologies Inc. Announces Resignation of Mathieu Lampron as Chief Product Officer and Chief Operating OfficerCarebook Technologies Inc. announced that Mathieu Lampron, Carebook's Chief Product Officer and Chief Operating Officer, has announced that after nearly 7 years with Carebook, he is leaving the Company effective June 23, 2023, to pursue another opportunity. It is currently anticipated that Mr. Lampron's former responsibilities will be assigned to existing Carebook team members and that the Company will not be seeking a replacement chief product officer or a replacement chief operating officer in the near future.공시 • May 24Carebook Technologies Inc. announced that it has received CAD 1.25 million in funding from ICM LimitedOn May 23, 2023, Carebook Technologies Inc. closed the transaction. The transaction has been conditionally approved by the TSX Venture Exchange (the "Exchange") and the listing of the Common Shares issued under the Transaction and the Common Shares issuable upon the exercise of the Warrants, as applicable. The Common Shares and the Warrants issued under the Transaction, as well as the Common Shares issuable upon exercise of the Warrants, are subject to a restricted period under applicable Canadian securities laws of four months and one day following the date hereof, ending on September 24, 2023.공시 • May 17Carebook Technologies Inc. announced that it expects to receive CAD 1.25 million in funding from ICM LimitedCarebook Technologies Inc. announced a non-brokered private placement of up to 12,500,000 units at the price of CAD 0.10 per unit for gross proceeds of up to CAD 1,250,000 on May 15, 2023. Each Unit will consist of one common share and 0.015 common share purchase warrant. Each whole Warrant will entitle its holder to acquire, on payment of CAD 0.15 to the Company, one Common Share for a period ending on the second anniversary of the Closing Date. The transaction will include participation from returning investor UIL Limited, a fund managed by ICM Limited. The closing of the transaction is subject to certain conditions, including the approval of the TSX Venture Exchange and certain other conditions customary to a transaction of this nature. All securities issued pursuant to the transaction will be subject to a statutory four month and one day hold period from the Closing Date. The transaction is expected to close on May 17, 2023.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 CRBK.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: CRBK.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Carebook Technologies 배당 수익률 vs 시장CRBK.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (CRBK.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.1%업계 평균 (Healthcare Services)1.2%분석가 예측 (CRBK.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 CRBK.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 CRBK.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 CRBK.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: CRBK.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2025/02/25 18:34종가2024/12/19 00:00수익2024/09/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Carebook Technologies Inc.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Douglas TaylorCanaccord Genuity
공시 • Feb 25+ 1 more updateCarebook Technologies' Common Shares to be Delisted from the TSX Venture Exchange at the Close of Trading on or about February 25, 2025Carebook Technologies Inc. (‘Carebook’ or the ‘Company’) announced the closing of the previously announced plan of arrangement (the ‘Transaction’) pursuant to which UIL Limited (‘UIL’) has acquired all of the common shares of Carebook (the ‘Common Shares’) not already owned by UIL and its affiliates or associates, at a price of $0.10 per Common Share (the ‘Consideration’), for aggregate consideration to the shareholders of Carebook (other than UIL and its associates or associates) of $4,170,618.90. The Transaction received overwhelming support from the Company's shareholders at a special meeting held on February 18, 2025, and the Transaction received final court approval on February 20, 2025. As a result of the Transaction, the Common Shares are expected to be delisted from the TSX Venture Exchange (‘TSXV’) at the close of trading on or about February 25, 2025. The Company also intends to submit an application to cease to be a reporting issuer under applicable Canadian securities laws and to otherwise terminate the Company's public reporting requirements.
공시 • Jan 03UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million.UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million on January 2, 2025. UIL will acquire all of the common shares (the "Common Shares") in the capital of Carebook, other than those Common Shares already owned by UIL or its affiliates and associates, by way of a plan of arrangement (the "Arrangement"). Pursuant to the Arrangement, holders of Common Shares, other than those Common Shares already owned by UIL or its affiliates and associates, will receive CAD 0.10 per Common Share (the "Consideration"). The Consideration represents a premium of approximately 122%, to the closing price of the Common Shares of CAD 0.045 on the TSX Venture Exchange (the "TSXV") on January 2, 2025, the last trading day prior to the announcement of the Arrangement. Completion of the Arrangement is subject to court approval and various closing conditions, including the approval of at least (i) two-thirds (66 2/3%) of the votes cast by shareholders present in person or represented by proxy at the special meeting of the shareholders to be called to approve the Arrangement (the "Special Meeting") (each holder of Common Shares being entitled to one vote per Common Share) and (ii) the approval of a simple majority of the holders of Common Shares present in person or represented by proxy at the Special Meeting, excluding the votes of UIL and its affiliates and associates and any other shareholders required to be excluded for purposes of the "minority approval" requirement under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ("MI 61-101") in the context of a "business combination" (the "Minority Shareholders"). Further details regarding applicable voting requirements will be contained in a management information circular to be filed on SEDAR+ at www.sedarplus.com and mailed to Carebook's shareholders in connection with the Special Meeting to approve the Arrangement. The signing of the Arrangement Agreement and the approval of the Arrangement followed the unanimous approval of the board of directors of the Company (the "Board") (with Alasdair Younie abstaining) following the unanimous recommendation of a committee of independent directors (the "Special Committee") of the Board. The Arrangement is expected to close in the first quarter of 2025, subject to the satisfaction of customary closing conditions. The Arrangement will be completed pursuant to a court-approved plan of arrangement under section 192 of the Canada Business Corporations Act and is subject to satisfaction of customary closing conditions for transactions of this nature, including court approval and the approval of the shareholders of Carebook, as further set out below. Immediately following the completion of the Arrangement, the Common Shares will be delisted from the TSXV and it is anticipated that the Company will make an application to cease to be a reporting issuer, following the approval of which, the Company will no longer be subject to the reporting requirements of applicable Canadian securities legislation. BDO Canada LLP is acting as financial advisor and fairness opinion provider to the Special Committee, and Stikeman Elliott LLP is acting as legal advisor to the Special Committee and the Company. Norton Rose Fulbright Canada LLP is acting as legal advisor to UIL on the proposed transaction.
공시 • Nov 08Carebook Technologies Inc. to Report Q3, 2024 Results on Nov 15, 2024Carebook Technologies Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 15, 2024
공시 • Aug 22Carebook Technologies Inc. Provides Earnings Guidance for the Fiscal Year 2024Carebook Technologies Inc. provided earnings guidance for the fiscal year 2024. For the period, the company continues to be positive for 2024 poised to achieve significant revenue growth.
공시 • Aug 15Carebook Technologies Inc. to Report Q2, 2024 Results on Aug 21, 2024Carebook Technologies Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 21, 2024
공시 • May 11Carebook Technologies Inc. to Report Q1, 2024 Results on May 15, 2024Carebook Technologies Inc. announced that they will report Q1, 2024 results at 9:30 AM, US Eastern Standard Time on May 15, 2024
공시 • Apr 03Carebook Technologies Inc. Provides Earnings Guidance for the Full Year 2024Carebook Technologies Inc. provided earnings guidance for the full year 2024. The company's financial outlook continues to be positive for 2024. The company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. The company's strong organic growth and efficient cost management initiatives will allow the company to continue to successfully execute on its strategy.
공시 • Apr 02Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024Carebook Technologies Inc., Annual General Meeting, Jun 13, 2024.
공시 • Mar 19Carebook Technologies Inc. to Report Fiscal Year 2023 Results on Apr 01, 2024Carebook Technologies Inc. announced that they will report fiscal year 2023 results at 9:30 AM, US Eastern Standard Time on Apr 01, 2024
공시 • Dec 12Carebook Technologies Inc. announced that it has received CAD 2 million in funding from ICM LimitedOn December 11, 2023, Carebook Technologies Inc. closed the transaction.
공시 • Oct 24Carebook Technologies Inc. to Report Q3, 2023 Results on Nov 10, 2023Carebook Technologies Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 10, 2023
공시 • Aug 23Carebook Technologies Inc. Provides Earnings Guidance for the Year 2023Carebook Technologies Inc. provided earnings guidance for the year 2023. For the period, the company expects financial outlook continues to be positive for 2023. The Company is poised to achieve significant revenue growth while effectively managing its costs and delivering sustained growth in cashflows. Carebook's strong organic growth and efficient cost management initiatives will allow the Company to continue to successfully execute on its strategy. Carebook is expecting to maintain strong performance in 2023 for the entire Company as a whole.
공시 • Aug 09Carebook Technologies Inc. to Report Q2, 2023 Results on Aug 22, 2023Carebook Technologies Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 22, 2023
공시 • Jun 29Carebook Technologies Inc. Announces Resignation of Mathieu Lampron as Chief Product Officer and Chief Operating OfficerCarebook Technologies Inc. announced that Mathieu Lampron, Carebook's Chief Product Officer and Chief Operating Officer, has announced that after nearly 7 years with Carebook, he is leaving the Company effective June 23, 2023, to pursue another opportunity. It is currently anticipated that Mr. Lampron's former responsibilities will be assigned to existing Carebook team members and that the Company will not be seeking a replacement chief product officer or a replacement chief operating officer in the near future.
공시 • May 24Carebook Technologies Inc. announced that it has received CAD 1.25 million in funding from ICM LimitedOn May 23, 2023, Carebook Technologies Inc. closed the transaction. The transaction has been conditionally approved by the TSX Venture Exchange (the "Exchange") and the listing of the Common Shares issued under the Transaction and the Common Shares issuable upon the exercise of the Warrants, as applicable. The Common Shares and the Warrants issued under the Transaction, as well as the Common Shares issuable upon exercise of the Warrants, are subject to a restricted period under applicable Canadian securities laws of four months and one day following the date hereof, ending on September 24, 2023.
공시 • May 17Carebook Technologies Inc. announced that it expects to receive CAD 1.25 million in funding from ICM LimitedCarebook Technologies Inc. announced a non-brokered private placement of up to 12,500,000 units at the price of CAD 0.10 per unit for gross proceeds of up to CAD 1,250,000 on May 15, 2023. Each Unit will consist of one common share and 0.015 common share purchase warrant. Each whole Warrant will entitle its holder to acquire, on payment of CAD 0.15 to the Company, one Common Share for a period ending on the second anniversary of the Closing Date. The transaction will include participation from returning investor UIL Limited, a fund managed by ICM Limited. The closing of the transaction is subject to certain conditions, including the approval of the TSX Venture Exchange and certain other conditions customary to a transaction of this nature. All securities issued pursuant to the transaction will be subject to a statutory four month and one day hold period from the Closing Date. The transaction is expected to close on May 17, 2023.